Literature DB >> 21629614

Infective endocarditis: Updated guidelines.

U Allen1.   

Abstract

The most recent revision of the American Heart Association guidelines on infective endocarditis prophylaxis occurred in 2007. These revisions were based on the fact that current data have brought into question the benefit of previous recommendations for infective endocarditis prophylaxis. It was noted that the bacteremia that occurs following dental procedures represents only a fraction of the episodes of bacteremia that occur with activities of daily living (such as chewing, brushing teeth and other oral hygiene measures). The target groups and the procedures for which prophylaxis is reasonable have been significantly reduced in number. The focus is now on patients who are most likely to have adverse outcomes from infectious endocarditis. The present article is targeted at practicing Canadian physicians and provides the rationale for the current recommendations. In addition to a summary of the indications for prophylaxis, information is provided on the conditions for which prophylaxis is not recommended.

Entities:  

Keywords:  Bacteremia; Congenital heart disease; Infective endocarditis; Prophylaxis

Year:  2010        PMID: 21629614      PMCID: PMC2912107          DOI: 10.1155/2010/760276

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  10 in total

1.  Prosthetic valve endocarditis.

Authors:  W R Wilson; P M Jaumin; G K Danielson; E R Giuliani; I I Washington JA; J E Geraci
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

2.  Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

Authors:  F K Gould; T S J Elliott; J Foweraker; M Fulford; J D Perry; G J Roberts; J A T Sandoe; R W Watkin
Journal:  J Antimicrob Chemother       Date:  2006-04-19       Impact factor: 5.790

3.  Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.

Authors:  D J Sexton; M J Tenenbaum; W R Wilson; J M Steckelberg; A D Tice; D Gilbert; W Dismukes; R H Drew; D T Durack
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

4.  Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility.

Authors:  P Francioli; J Etienne; R Hoigné; J P Thys; A Gerber
Journal:  JAMA       Date:  1992-01-08       Impact factor: 56.272

5.  How important are dental procedures as a cause of infective endocarditis?

Authors:  W G Guntheroth
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

Review 6.  Dentists are innocent! "Everyday" bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children.

Authors:  G J Roberts
Journal:  Pediatr Cardiol       Date:  1999 Sep-Oct       Impact factor: 1.655

7.  Prosthetic valve endocarditis.

Authors:  W R Wilson; G K Danielson; E R Giuliani; J E Geraci
Journal:  Mayo Clin Proc       Date:  1982-03       Impact factor: 7.616

8.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Walter Wilson; Kathryn A Taubert; Michael Gewitz; Peter B Lockhart; Larry M Baddour; Matthew Levison; Ann Bolger; Christopher H Cabell; Masato Takahashi; Robert S Baltimore; Jane W Newburger; Brian L Strom; Lloyd Y Tani; Michael Gerber; Robert O Bonow; Thomas Pallasch; Stanford T Shulman; Anne H Rowley; Jane C Burns; Patricia Ferrieri; Timothy Gardner; David Goff; David T Durack
Journal:  Circulation       Date:  2007-04-19       Impact factor: 29.690

9.  Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.

Authors:  Michael A Gerber; Robert S Baltimore; Charles B Eaton; Michael Gewitz; Anne H Rowley; Stanford T Shulman; Kathryn A Taubert
Journal:  Circulation       Date:  2009-02-26       Impact factor: 29.690

10.  Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci.

Authors:  W R Wilson; J E Geraci; C J Wilkowske; J A Washington
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

  10 in total
  2 in total

1.  Implantable cardioverter defibrillator lead-related methicillin resistant Staphylococcus aureus endocarditis: Importance of heightened awareness.

Authors:  Obiora F Anusionwu; Cheri Smith; Alan Cheng
Journal:  World J Cardiol       Date:  2012-07-26

Review 2.  Valvular heart disease and anaesthesia.

Authors:  Abhijit Paul; Sucharita Das
Journal:  Indian J Anaesth       Date:  2017-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.